Hafnia alvei Urosepsis in a Kidney Transplant Patient

Table 2

H. alvei infections in transplant recipients.

Author	Age	Sex	Underlying disease	Type of transplant	Immunosuppression	Risk factors	Antibiotic treatment	Outcome
Savini et al. [5]	9	F	Fanconi’s anaemia	Allogeneic stem cells	Cyclosporine steroids; antilymphocyte antibody	Graft versus host disease	Ceftazidime, amikacin, and teicoplanin	Cured
Barry et al. [6]	61	F	Primary biliary cirrhosis	Liver	Unknown	Recurrent rejection, additional infection	Piperacillin/; tazobactam, gentamicin, and amphotericin B	Died
Barry et al. [6]	2	M	Autoimmune hepatitis	Liver	Unknown	Previous high dose steroids and OKT3 therapy	Trimethoprim/; sulfamethoxazole, gentamicin, and ampicillin	Cured
Cardile et al. [7]	45	F	Diabetic nephropathy	Kidney	Tacrolimus; MMF; prednisone	Diabetes; ureteral stent	Cefixime	Cured
Benito et al. [8]	69	F	Autosomal dominant polycystic kidney disease	Kidney	Cyclosporine azathioprine steroids	Hepatitis C	Imipenem and clarithromycin	Cured
This study	56	F	IgA nephropathy	Kidney	Tacrolimus azathioprine	None	Cefepime and ciprofloxacin	Cured